Europe Medical Cannabis Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Europe Medical Cannabis Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Europe Medical Cannabis Market Industry
  Trends, Share, Size, Growth, Opportunity and
  Forecast 2024-2032," the Europe medical cannabis
  market size reached US 2,167.8 Million in 2023.
• Medical cannabis, also known as medical
  marijuana, refers to the use of the cannabis
  plant or its extracts to treat various medical
  conditions and alleviate symptoms. The plant
  contains over 100 different cannabinoids, with
  tetrahydrocannabinol (THC) and cannabidiol (CBD)
  being the most well-known and studied. These
  cannabinoids interact with the body's
  endocannabinoid system, which plays a crucial
  role in regulating various physiological
  functions, including pain sensation, mood,
  appetite, and memory. Medical cannabis can be
  administered through various methods, including
  smoking, vaporization, ingestion of capsules or
  edibles, and topical application.
• It has been used for centuries for its
  therapeutic properties and is now gaining
  increasing recognition and acceptance within the
  medical community for its potential in managing
  chronic pain, nausea and vomiting, muscle spasms,
  seizures, inflammation, and other conditions.
  Medical cannabis is typically prescribed by
  healthcare professionals in jurisdictions where
  it is legal, and patients may obtain it from
  licensed dispensaries or pharmacies.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/europe-medical-cannabis
  -market/requestsample

4
Report Description

• Europe Medical Cannabis Market Trends
• The Europe medical cannabis market is
  experiencing significant growth driven by the
  growing body of scientific research supporting
  the therapeutic benefits of medical cannabis
  across a wide range of medical conditions. This
  increasing evidence base is leading to greater
  acceptance and adoption of medical cannabis among
  healthcare professionals and patients alike.
  Besides, there is a rising demand for alternative
  treatment options, particularly for chronic and
  debilitating conditions where conventional
  therapies may be inadequate or associated with
  undesirable side effects. Medical cannabis offers
  a promising alternative or adjunctive therapy for
  patients seeking relief from symptoms such as
  chronic pain, spasticity, and chemotherapy-induced
  nausea and vomiting.
• Moreover, there is a shifting regulatory
  landscape across Europe, with an increasing
  number of countries legalizing medical cannabis
  or expanding access to it for medical purposes.
  This trend is driven by evolving attitudes
  towards cannabis, as well as recognition of its
  potential economic benefits, including job
  creation, tax revenue, and reduced burden on
  healthcare systems. Additionally, there is a
  growing trend toward medicalization and
  standardization of cannabis products, with
  companies investing in research, development, and
  quality control to ensure consistency, safety,
  and efficacy. This includes the development of
  pharmaceutical-grade cannabis-based medicines, as
  well as innovative delivery methods and
  formulations tailored to specific patient needs.
  Overall, these drivers and trends are expected to
  fuel continued growth and expansion of the Europe
  medical cannabis market in the coming years,
  presenting opportunities for companies to
  capitalize on this burgeoning industry.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/europe-medical-cannabis
  -market

5
Report Segmentation

• Breakup by Species
• Indica
• Sativa
• Hybrid
•  
• Breakup by Derivative
• Cannabidiol (CBD)
• Tetrahydrocannabinol (THC)
• Others
• Breakup by Application
• Cancer
• Arthritis
• Migraine

6
Report Segmentation

• Epilepsy
• Others
• Breakup by End Use
• Pharmaceutical Industry
• Research and Development Centers
• Others
•  
• Breakup by Route of Administration
• Oral Solutions and Capsules
• Smoking
• Vaporizers
• Topicals
• Others

7
Report Segmentation

• Breakup by Country
• Germany
• France
• United Kingdom
• Italy
• Spain
• Others

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Europe Medical Cannabis
  Market    5.1    Market Overview    5.2  
   Market Performance    5.3    Impact of
  COVID-19  5.4    Market Forecast
• 6     Market Breakup by Species
• 6.1 Indica
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Sativa
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 6.3 Hybrid
• 6.3.1 Market Trends
• 6.3.2 Market Forecast
• 7 Market Breakup by Derivative       

11
Table of Contents

• 7.1 Cannabidiol (CBD)
• 7.1.1 Market Trends
• 7.1.2 Market Forecast
• 7.2 Tetrahydrocannabinol (THC)
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Others
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 8 Market Breakup by Application
• 8.1 Cancer
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Arthritis
• 8.2.1 Market Trends
• 8.2.2 Market Forecast
• 8.3 Migraine
• 8.3.1 Market Trends
• 8.3.2 Market Forecast

12
Partial List of Clients
13
Partial List of Clients
14
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

15
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us